Annexon, Inc. (ANNX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US03589W1027
Annexon, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -216.41 m USD |
| EBIT | -206.69 m USD |
| Net income | -206.69 m USD |
| Diluted EPS – continuing operations | -1.34 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Annexon, Inc.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. It is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
More stocks
- New Mountain Finance Corp (NMFC)
- Kyobo Securiti (030610.KS)
- Fuda Alloy Materials Co Ltd (603045.SS)
- Public Property Invest ASA (PUBLI.OL)
- Zhongjie (Jiangsu) Technology Co.Ltd. (301072.SZ)
- i3 Verticals, Inc. (IIIV)
- Silex Systems Ltd (SLX.AX)
- Feitian Technologies Co Ltd (300386.SZ)
- Fuan Pharmaceutical Group Co (300194.SZ)
- PVA TePla (TPE.DE)
- SMITH & WESSON BRANDS, INC. (SWBI)
- PAPA JOHNS INTERNATIONAL INC (PZZA)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.